Bridgeway Capital Management’s Avita Medical RCEL Stock Holding History

Bridgeway Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$112K	Sell	30,404 -87,600	-74%	-$368K	﹤0.01%	1115
2025 Q4	$407K	Hold	118,004	–	–	0.01%	864
2025 Q3	$603K	Buy	118,004 +80,404	+214%	+$420K	0.01%	767
2025 Q2	$199K	Buy	+37,600	New	+$274K	﹤0.01%	962
2024 Q1	–	Sell	-28,518	Closed	-$391K	–	1364
2023 Q4	$391K	Hold	28,518	–	–	0.01%	1000
2023 Q3	$417K	Hold	28,518	–	–	0.01%	931
2023 Q2	$485K	Hold	28,518	–	–	0.01%	913
2023 Q1	$398K	Hold	28,518	–	–	0.01%	934
2022 Q4	$188K	Buy	+28,518	New	+$171K	﹤0.01%	1098

Other funds holding RCEL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bridgeway Capital Management's RCEL Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Avita Medical (RCEL) stake by 74% in Q1 2026, selling an estimated $368K and leaving 30,404 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

Bridgeway Capital Management first reported a position in RCEL in Q4 2022 and has held it in 9 quarters since. The position peaked at $603K in Q3 2025. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

Bridgeway Capital Management held 30,404 shares of Avita Medical worth $112K as of Q1 2026.
Bridgeway Capital Management sold 87,600 Avita Medical shares in Q1 2026, an estimated $368K.
Avita Medical made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1115 holding.
Bridgeway Capital Management first reported a position in Avita Medical in Q4 2022 and has held it in 9 quarters since.
Bridgeway Capital Management's Avita Medical position peaked at $603K in Q3 2025.
79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.